Filing Flows › AbbVie (ABBV) › Operating margin
AbbVie (ABBV) operating margin by quarter
AbbVie's operating margin was 36.0% in Q3 2026 (third quarter 2026), -1.8 pts from Q2 2026. Over the last 7 quarters it ranged from 12.1% (Q3 2025) to 37.9% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 36.0% | -1.8 pts | +23.9 pts |
| Q2 2026 | 37.9% | +11.3 pts | +6.1 pts |
| Q1 2026 | 26.6% | -0.7 pts | -1.4 pts |
| Q4 2025 | 27.3% | +15.3 pts | — |
| Q3 2025 | 12.1% | -19.7 pts | — |
| Q2 2025 | 31.7% | +3.8 pts | — |
| Q1 2025 | 28.0% | — | — |
Q3 2026 at a glance
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is AbbVie's operating margin?
AbbVie's operating margin was 36.0% in Q3 2026 (third quarter 2026), -1.8 pts from Q2 2026.
How has AbbVie's operating margin changed?
Over the last 7 quarters it ranged from 12.1% (Q3 2025) to 37.9% (Q2 2026).